Patients taking GLP-1 medications with insulin or sulfonylureas have an increased risk of hypoglycemia and should discuss timing of all medications with their healthcare provider to minimize this risk
The study flagged significant PFAS accumulation in this group, particularly PFHpS, PFUnA, and others, likely from everyday contact with contaminated gowns, gloves, and masks
She accessed the drug through Ro and is now partnering with the telehealth company to talk about her experience
doi: 10.1038/nm.3128 133 GBD 2015 Risk Factors Collaborators
While several biotech companies are in the preclinical or early clinical trial phases of developing these microneedle patches, they are still years away from being reviewed by the FDA and available to the public
Diabetes 59 , 30993107 (2010)